Shing M Lee (Shing Lee)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 21

Top Topics

Finite Element Analysis

Drug Administration

Top Venues

Clinical trials (London, England)

JCO clinical cancer informatics

Statistics in medicine

JCO oncology practice

This page only lists publications with an associated author ORCID identifier.

Publications

Lucie Biard, Anaïs Andrillon, Rebecca B Silva, Shing M Lee
Dose optimization for cancer treatments with considerations for late-onset toxicities. Clinical trials (London, England) (2024)
Lucie Biard, Anaïs Andrillon, Rebecca B Silva, Shing M Lee
Dose optimization for cancer treatments with considerations for late-onset toxicities. Clinical trials (London, England) 21 (3) (2024)
Lucie Biard, Anaïs Andrillon, Rebecca B Silva, Shing M Lee
Dose optimization for cancer treatments with considerations for late-onset toxicities. Clinical trials (London, England) 21 (3) (2024)
Lucie Biard, Anaïs Andrillon, Rebecca B Silva, Shing M Lee
Dose optimization for cancer treatments with considerations for late-onset toxicities. Clinical trials (London, England) 21 (3) (2024)
Lucie Biard, Anaïs Andrillon, Rebecca B Silva, Shing M Lee
Dose optimization for cancer treatments with considerations for late-onset toxicities. Clinical trials (London, England) 21 (3) (2024)
Shing M Lee, Weijia Fan, Aijin Wang, Riha Vaidya, Mary W Redman, Scott N Gettinger, Lyudmila Bazhenova, Roy S Herbst, Dawn L Hershman, Joseph M Unger
Novel Approaches for Dynamic Visualization of Adverse Event Data in Oncology Clinical Trials: A Case Study Using Immunotherapy Trial S1400-I (SWOG). JCO clinical cancer informatics 7 (2023)
Shing M Lee, Weijia Fan, Aijin Wang, Riha Vaidya, Mary W Redman, Scott N Gettinger, Lyudmila Bazhenova, Roy S Herbst, Dawn L Hershman, Joseph M Unger
Novel Approaches for Dynamic Visualization of Adverse Event Data in Oncology Clinical Trials: A Case Study Using Immunotherapy Trial S1400-I (SWOG). JCO clinical cancer informatics 7 (2023)
Shing M Lee, Weijia Fan, Aijin Wang, Riha Vaidya, Mary W Redman, Scott N Gettinger, Lyudmila Bazhenova, Roy S Herbst, Dawn L Hershman, Joseph M Unger
Novel Approaches for Dynamic Visualization of Adverse Event Data in Oncology Clinical Trials: A Case Study Using Immunotherapy Trial S1400-I (SWOG). JCO clinical cancer informatics 7 (2023)
Shing M Lee, Weijia Fan, Aijin Wang, Riha Vaidya, Mary W Redman, Scott N Gettinger, Lyudmila Bazhenova, Roy S Herbst, Dawn L Hershman, Joseph M Unger
Novel Approaches for Dynamic Visualization of Adverse Event Data in Oncology Clinical Trials: A Case Study Using Immunotherapy Trial S1400-I (SWOG). JCO clinical cancer informatics 7 (2023)
Morgan R L Lichtenstein, Melissa P Beauchemin, Rohit Raghunathan, Shing M Lee, Sahil D Doshi, Cynthia Law, Melissa K Accordino, Elena B Elkin, Jason D Wright, Dawn L Hershman
Association Between Copayment Assistance, Insurance Type, Prior Authorization, and Time to Receipt of Oral Anticancer Drugs. JCO oncology practice (2023)
Shing M Lee, Weijia Fan, Aijin Wang, Riha Vaidya, Mary W Redman, Scott N Gettinger, Lyudmila Bazhenova, Roy S Herbst, Dawn L Hershman, Joseph M Unger
Novel Approaches for Dynamic Visualization of Adverse Event Data in Oncology Clinical Trials: A Case Study Using Immunotherapy Trial S1400-I (SWOG). JCO clinical cancer informatics 7 (2023)
Matthew A Ingham, Shing M Lee, Brian Andrew Van Tine, Edwin Choy, Jay Oza, Sahil D Doshi, Liner Ge, Peter Oppelt, Gregory M Cote, Brian Corgiat, Naomi Sender, Sarah Sta Ana, Lavan Panchalingam, Emanuel F Petricoin, Gary K Schwartz
A Single-Arm Phase II Trial of Sitravatinib in Advanced Well-Differentiated/Dedifferentiated Liposarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (6) (2023)
Anaïs Andrillon, Sylvie Chevret, Shing M Lee, Lucie Biard
Surv-CRM-12: A Bayesian phase I/II survival CRM for right-censored toxicity endpoints with competing disease progression. Statistics in medicine 41 (29) (2022)
Matthew A Ingham, Shing M Lee, Brian Andrew Van Tine, Edwin Choy, Jay Oza, Sahil D Doshi, Liner Ge, Peter Oppelt, Gregory M Cote, Brian Corgiat, Naomi Sender, Sarah Sta Ana, Lavan Panchalingam, Emanuel F Petricoin, Gary K Schwartz
A single-arm phase 2 trial of Sitravatinib in advanced well-differentiated/dedifferentiated liposarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Melissa P Beauchemin, Morgan R L Lichtenstein, Rohit Raghunathan, Sahil D Doshi, Shing M Lee, Cynthia Law, Melissa K Accordino, Elena B Elkin, Jason D Wright, Dawn L Hershman
Impact of a Hospital-Based Specialty Pharmacy in Partnership With a Care Coordination Organization on Time to Delivery and Receipt of Oral Anticancer Drugs. JCO oncology practice (2022)
Rebecca B Silva, Christina Yap, Richard Carvajal, Shing M Lee
Would the Recommended Dose Have Been Different Using Novel Dose-Finding Designs? Comparing Dose-Finding Designs in Published Trials. JCO precision oncology 5 (2021)
Lucie Biard, Shing M Lee, Bin Cheng
Seamless phase I/II design for novel anticancer agents with competing disease progression. Statistics in medicine 40 (21) (2021)
Shing M Lee, Denise A Esserman, Ken Cheung, James Dziura, Peter Peduzzi, Magdalena Sobieszczyk
What do we do with our under-enrolled single-center COVID-19 clinical trials? Clinical trials (London, England) 18 (6) (2021)
Shing M Lee, Jieling Miao, Ruby Wu, Joseph M Unger, Ken Cheung, Dawn L Hershman
A comparison of nurses' and physicians' perception of cancer treatment burden based on reported adverse events. Health and quality of life outcomes 17 (1) (2019)
Shing M Lee, Xiaoqi Lu, Bin Cheng
Incorporating patient-reported outcomes in dose-finding clinical trials. Statistics in medicine 39 (3) (2019)
Shing M Lee, Dawn L Hershman, Jieling Miao, Xiaobo Zhong, Joseph M Unger, Ying Kuen Ken Cheung
Estimating global treatment toxicity burden from adverse-event data. Cancer 124 (4) (2017)